Karo Bio appoints Per Bengtsson acting president and CEO
This article was originally published in Scrip
Executive Summary
Karo Bio has named Per Bengtsson acting president and CEO after Fredrik Lindgren, former CEO of Karo Bio, left the company on 23 May 2011. Mr Bengtsson has previously been CEO of Probi, R&D manager at Pharmacia/Pharmacia&Upjohn Plasma Products and medical director and therapeutic area head at Ferring.